IB Acquisition Corp. (IBACR) cash flow statement

IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$0.10−0.00 (-3.50%)

Close on Oct 30, 2026Market cap $54.39MP/E –Yield –

IB Acquisition Corp. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q3 2026 2026-06-30	Q2 2026 2026-03-31	Q1 2026 2025-12-31	Q4 2025 2025-09-30	Q3 2025 2025-06-30	Q2 2025 2025-03-31	Q1 2025 2024-12-31	Q4 2024 2024-09-30	Q3 2024 2024-06-30	Q2 2024 2024-03-31	Q1 2024 2023-12-31	Q4 2023 2023-09-30	Q3 2023 2023-06-30
Change in Accounts Payable	-0.18	0.59	0.02	0.05	-0.07	0.00	0.00	0.05	-0.10	0.11	0.01	–	–
Operating Cash Flow	-0.47	-0.27	-1.05	-0.06	-0.14	-0.74	-0.38	-0.05	-0.59	-0.10	-0.08	0.00	0.00
Purchase of Investments	–	–	–	–	–	–	–	0	0	–	–	–	–
Investing Cash Flow	0	–	–	107	0	0.61	0.32	0	0	–	–	–	–
Share Repurchases	0	–	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	0.50	–	–	–	–	–	0.15	0	-0.20	117	0.21	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 1587.2%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –